Press Releases

Honeywell's Knight Elected to HCPC's Board of Directors November 20, 2006   MORRIS TOWNSHIP, N.J., Nov. 20, 2006 - Honeywell (NYSE: HON) announced today that Rick Knight has been elected to serve on the Board of Directors for the Healthcare Compliance Packaging Council (HCPC). The appointment is a two-year term.   "I am honored to be part of the HCPC's continued overall mission to promote the benefits of unit dose blister packaging, particularly in the areas of improved patient adherence and reductions in adverse drug incidents," said Knight, global business manager for Honeywell's healthcare specialty films business. "Honeywell is committed to educating the entire packaging value chain about the unique benefits of thermoformed blister packaging. We are dedicated to ensuring that pharma receives the right packaging material for the right medication at the lowest possible total cost."   Honeywell recently hosted the HCPC 2006 Showcase at its headquarters in Morristown, N.J. The one-day event, which was attended by major pharmaceutical companies as well as healthcare packaging suppliers, converters and other industry specialists, focused on the future of healthcare packaging and cost reduction strategies.   Honeywell manufactures and supplies Aclar® film, a polychlorotrifluoroethylene (PCTFE), which is used widely in pharmaceutical and medical packaging. The material is crystal clear, biochemically inert, chemical-resistant, nonflammable, plasticizer- and stabilizer-free and offers superior moisture barrier properties.   Pharmaceutical noncompliance costs the U.S. economy an estimated $100 billion every year, and is blamed for more than 125,000 American deaths annually, according to the HCPC.   The HCPC is a not-for-profit trade association established in 1990.   Honeywell International is a $31 billion diversified technology and manufacturing leader, serving customers worldwide with aerospace products and services; control technologies for buildings, homes and industry; automotive products; turbochargers; and specialty materials. Based in Morris Township, N.J., Honeywell's shares are traded on the New York, London, Chicago and Pacific Stock Exchanges. It is one of the 30 stocks that make up the Dow Jones Industrial Average and is also a component of the Standard & Poor's 500 Index. For additional information, please visit www.honeywell.com.   Honeywell Specialty Materials, based in Morristown, N.J., is a $4.5 billion, global leader in providing customers with high-performance specialty materials, including fluorine products; specialty films and additives; advanced fibers and composites; intermediates; specialty chemicals; electronic materials and chemicals; and technologies and materials for petroleum refining.   This report contains "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934. All statements, other than statements of fact, that address activities, events or developments that we or our management intend, expect, project, believe or anticipate will or may occur in the future are forward-looking statements. Forward-looking statements are based on management's assumptions and assessments in light of past experience and trends, current conditions, expected future developments and other relevant factors. They are not guarantees of future performance, and actual results, developments and business decisions may differ from those envisaged by our forward-looking statements. Our forward-looking statements are also subject to risks and uncertainties, which can affect our performance in both the near and long-term. We identify the principal risks and uncertainties that affect our performance in our Form 10-K and other filings with the Securities and Exchange Commission.   Contact: Robert Donohoe 973-455-4114 Robert.Donohoe@honeywell.com